{"id":210713,"url":"https://lda.senate.gov/api/v1/clients/210713/?format=json","client_id":125,"name":"REGENXBIO","general_description":"Develop innovative therapies to treat patients with rare or otherwise debilitating disease","client_government_entity":false,"client_self_select":null,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-05-03","registrant":{"id":40036301,"url":"https://lda.senate.gov/api/v1/registrants/40036301/?format=json","house_registrant_id":39935,"name":"KNIGHT CAPITOL CONSULTANTS","description":"Government Relations","address_1":"817 North Lincoln Street","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22201","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PATRICIA KNIGHT","contact_telephone":"+1 202-510-5264","dt_updated":"2026-03-31T21:14:47.305082-04:00"}}